NovoCure Ltd. is a company in the U.S. stock market and it is a holding in 94 U.S.-traded ETFs. NVCR has around 5.3M shares in the U.S. ETF market. The largest ETF holder of NVCR is the Vanguard Small-Cap ETF (VB), with approximately 699.98K shares. Investors may also find of interest that the ETF with the largest allocation to NVCR stock is BlueStar Israel Technology ETF (ITEQ), with a portfolio weight of 7.99%. On average, U.S. ETFs allocate 0.47% of NVCR to their portfolios.
Additionally, NVCR is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with NVCR as a holding is the iShares Morningstar Mid-Cap ETF (IMCB), with a return of 536.83%.